DTYMK and hematocrit: Using thyroid organoids as a tool, we found that the expression of DTWMK gradually decreased in HT organoids and PTC organoids, indicating that DTYMK may be related to the progression of HT to PTC and may be used as a potential therapeutic target for HT.